2023
Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy
Delamater P, Buttenheim A, Salmon D, Schwartz J, Omer S. Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy. JAMA 2023, 330: 1585-1587. PMID: 37782512, PMCID: PMC10546290, DOI: 10.1001/jama.2023.16995.Peer-Reviewed Original Research
2022
The legacy of the COVID-19 pandemic for childhood vaccination in the USA
Opel DJ, Brewer NT, Buttenheim AM, Callaghan T, Carpiano RM, Clinton C, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Schwartz JL, Benjamin RM, Caplan A, DiResta R, Lakshmanan R, Maldonado YA, Mello MM, Parmet WE, Salmon DA, Sharfstein JM, Omer SB. The legacy of the COVID-19 pandemic for childhood vaccination in the USA. The Lancet 2022, 401: 75-78. PMID: 36309017, PMCID: PMC9605265, DOI: 10.1016/s0140-6736(22)01693-2.Peer-Reviewed Original ResearchEffectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
Mello MM, Opel DJ, Benjamin RM, Callaghan T, DiResta R, Elharake JA, Flowers LC, Galvani AP, Salmon DA, Schwartz JL, Brewer NT, Buttenheim AM, Carpiano RM, Clinton C, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Sharfstein JM, Caplan A. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. The Lancet 2022, 400: 535-538. PMID: 35817078, PMCID: PMC9270060, DOI: 10.1016/s0140-6736(22)00875-3.Peer-Reviewed Original ResearchUnderstanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework
Ellingson MK, Bednarczyk RA, O’Leary S, Schwartz JL, Shapiro ED, Niccolai LM. Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework. Journal Of Behavioral Medicine 2022, 46: 356-365. PMID: 35194726, PMCID: PMC8862696, DOI: 10.1007/s10865-022-00296-4.Peer-Reviewed Original Research
2021
Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Commissioners of the Lancet Commission on Vaccine Refusal A, Hotez P, Cooney R, Benjamin R, Brewer N, Buttenheim A, Callaghan T, Caplan A, Carpiano R, Clinton C, DiResta R, Elharake J, Flowers L, Galvani A, Lakshmanan R, Maldonado Y, McFadden S, Mello M, Opel D, Reiss D, Salmon D, Schwartz J, Sharfstein J, Omer S. Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 2021, 397: 1165-1167. PMID: 33639088, DOI: 10.1016/s0140-6736(21)00372-x.Peer-Reviewed Original Research
2020
Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy
Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Affairs 2020, 40: 42-52. PMID: 33211536, PMCID: PMC7931245, DOI: 10.1377/hlthaff.2020.02054.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineVaccine efficacyCoronavirus disease 2019 (COVID-19) vaccinesSignificant vaccine hesitancyClinical outcomesClinical trialsVaccination programVaccine hesitancyEpidemic severityVaccineAuthorized vaccinesHealth officialsCumulative infectionsEfficacyVaccine productionDistribution programSeverityOutcomesUrgent needHospitalizationVaccinationInfectionTrialsGlobal effortsEvaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
Schwartz JL. Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust. New England Journal Of Medicine 2020, 383: 1703-1705. PMID: 32966716, DOI: 10.1056/nejmp2026393.Peer-Reviewed Original Research
2017
Vaccines and the Trump Administration-Reasons for Optimism Amid Uncertainty.
Schwartz JL. Vaccines and the Trump Administration-Reasons for Optimism Amid Uncertainty. American Journal Of Public Health 2017, 107: 1892-1893. PMID: 29048968, PMCID: PMC5678397, DOI: 10.2105/ajph.2017.304111.Peer-Reviewed Original ResearchUsing campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights
Nowak GJ, Shen AK, Schwartz JL. Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights. Vaccine 2017, 35: 5543-5550. PMID: 28886947, DOI: 10.1016/j.vaccine.2017.08.064.Peer-Reviewed Original ResearchConceptsAdult vaccinationAdult vaccinesSocial psychological notionHealthcare providersAdult immunization ratesPsychological notionsPsychological valueRecommended vaccinationsHealth communication literatureImmunization ratesIntegrative reviewCommunication literatureVaccinationValue perceptionsAdult HealthVaccineCommunication campaignsOverall usePerceptionPublic healthGreater supportUnited StatesHealthProvidersAssessmentAchieving an Optimal Childhood Vaccine Policy
Opel DJ, Schwartz JL, Omer SB, Silverman R, Duchin J, Kodish E, Diekema DS, Marcuse EK, Orenstein W. Achieving an Optimal Childhood Vaccine Policy. JAMA Pediatrics 2017, 171: 893-896. PMID: 28672396, DOI: 10.1001/jamapediatrics.2017.1868.Peer-Reviewed Original Research
2016
The Uncertain Future of Human Papillomavirus Vaccination School Requirements
Schwartz JL. The Uncertain Future of Human Papillomavirus Vaccination School Requirements. Pediatrics 2016, 138: e20163097. PMID: 27940739, DOI: 10.1542/peds.2016-3097.Peer-Reviewed Original ResearchState-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014.
Bernstein S, North A, Schwartz J, Niccolai LM. State-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014. American Journal Of Public Health 2016, 106: 1879-81. PMID: 27552268, PMCID: PMC5024388, DOI: 10.2105/ajph.2016.303381.Peer-Reviewed Original ResearchConceptsVoting patternsAdolescent vaccination coverageHuman papillomavirusRed statesLocal political settingPresidential election resultsVaccination coverageState-level associationsHealth care access characteristicsPolitical settingsElection resultsTetanus-containing vaccineCultural normsSocial valuesBlue statesAdolescent coverageAdolescent vaccinesMeningococcal vaccinationMultivariable modelVaccination policyPotential confoundingVaccinePolicyBoysGirlsVaccine Pricing and US Immunization Policies
Schwartz JL. Vaccine Pricing and US Immunization Policies. JAMA 2016, 316: 226-226. PMID: 27404201, DOI: 10.1001/jama.2016.6307.Peer-Reviewed Original ResearchWhen Not All That Counts Can Be Counted: Economic Evaluations And The Value Of Vaccination
Schwartz JL, Mahmoud A. When Not All That Counts Can Be Counted: Economic Evaluations And The Value Of Vaccination. Health Affairs 2016, 35: 208-211. PMID: 26858371, DOI: 10.1377/hlthaff.2015.1438.Peer-Reviewed Original Research
2012
Immune to addiction: the ethical dimensions of vaccines against substance abuse
Young MJ, Sisti DA, Rimon-Greenspan H, Schwartz JL, Caplan AL. Immune to addiction: the ethical dimensions of vaccines against substance abuse. Nature Immunology 2012, 13: 521-524. PMID: 22610239, DOI: 10.1038/ni.2321.Peer-Reviewed Original Research
2011
Ethics of vaccination programs
Schwartz JL, Caplan AL. Ethics of vaccination programs. Current Opinion In Virology 2011, 1: 263-267. PMID: 22440783, DOI: 10.1016/j.coviro.2011.05.009.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsHumansImmunization ProgramsInfluenza VaccinesInfluenza, HumanVaccinationViral VaccinesVirus DiseasesConceptsEthical challengesEthical issuesRisk controversiesEthicsFundamental principlesVaccination programUnique issuesHealth of individualsInfluenza vaccination campaignGlobal vaccination programsChildhood vaccinesIssuesVaccination activitiesVaccination campaignGlobal eradicationEventual designPublic healthControversyScientistsOngoing evaluationNationsPrinciplesRecent developmentsCommunityHealth